Inpatient Insomnia

Ben Johnson


Background 

  • Sleep disturbances in the hospital are multifactorial
  • Consequences of sleep disturbances include changes in cognition, behavior, anxiety, pain perception, respiratory function, inflammation, and metabolism

Management

  • Non-pharmacologic interventions (when medically appropriate):
    • Minimize:
      • Potential for overnight alarms (telemetry etc.)
      • Overnight vital signs
      • Overnight and early morning lab draws
      • Overnight IV fluids and late-night diuretics
    • Discourage daytime naps
      • Administer nighttime medications earlier in the evening
      • Turn off or mute the television
      • Close room doors
      • Encourage care team to be as quiet as possible overnight
      • Keep lights on during the day and off at night
      • Ensure patient has CPAP available if used at home
  • Pharmacotherapy:
    • Background
      • The best first step is to minimize medications such as sedative-hypnotics, opioids, glucocorticoids, beta blockers, and certain antibiotics that disturb sleep architecture
    • Medications
      • Melatonin: 1-5 mg PO qhs
        • First-line choice based on mild side-effect profile, low potential for drug-drug interactions, and improves circadian rhythms; Dose 2-3hrs before bedtime
      • Trazodone: 25-50 mg PO qhs (max 200 mg/day)
        • Side effects: headache, dry mouth, and nausea o Monitor for orthostasis and infrequent atrial arrhythmias; use lowest effective dose
      • Mirtazapine: 7.5-15 mg PO qHS
        • A primary alpha-2 antagonist with 5-HT2 and H1 antagonism
        • Consider when insomnia appears to be related to primary depression
        • Can increase appetite and cause weight gain

Additional Information 

  • Avoid the following in the inpatient setting:
    • Benzodiazepines
      • Reduces sleep latency and increases total sleep time but avoided due to significant adverse effects: respiratory depression, cognitive decline, delirium, daytime sleepiness, and falls, particularly in hospitalized older adults
    • Non-benzodiazepines benzodiazepine receptor agonists (e.g., zolpidem, eszopiclone/zopiclone, zaleplon) Commonly used in the outpatient setting but associated with cognitive dysfunction, delirium, and falls in hospitalized patients
    • Diphenhydramine
      • Trials evaluating its effectivenessas a sleep aid are limited and show mixed results
      • Many potential side effects that are enhanced in the inpatient setting: impaired cognition, anticholinergic effects (constipation, urinary retention)

Last updated on